Labroots is excited to present the 10th Annual Neuroscience Virtual Conference, to be broadcasted live on March 10th, 2022. This distinguished, online-only, event is free to attend and will once again bring together the neuroscience community to discuss and present the newest advances in understanding the human brain, neuropsychiatric disorders, and behavorial processes as it relates to the brain function.
The tracks for last years event included:
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the Neuroscience 2021 Virtual Event. Submission is free. Submit your abstract here.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 40 credits.
Use #LRneuro to follow the conversation!
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events
Research And Development
Labroots Registration (Also interested in)78%
WAVE Newsletter Promotion1%
Medical Laboratory Technician6%
Clinical Laboratory Scientist3%
Manufacturer & Biotech/pharma1%